Stockreport

Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Zoetis Inc. Class A  (ZTS) 
Last zoetis inc. class a earnings: 2/13 07:00 am Check Earnings Report
US:NYSE Investor Relations: investor.zoetis.com
PDF PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Lenivia® (izenivetmab [Read more]